Dermatological side effects of targeted antineoplastic therapies: a prospective study

2020 ◽  
Vol 39 (4) ◽  
pp. 380-384
Author(s):  
Senay Agirgol ◽  
Ceyda Çaytemel ◽  
Kezban Nur Pilanci
Keyword(s):  
Side Effects ◽  
Prospective Study ◽  
Dermatological Side Effects ◽  
A Prospective Study

A prospective study on patterns of topical steroids self‐use in dermatophytoses and determinants predictive of cutaneous side effects

2020 ◽  
Vol 33 (4) ◽  
Author(s):  
Ananta Khurana ◽  
Aastha Gupta ◽  
Kabir Sardana ◽  
Khushboo Sethia ◽  
Sanjeet Panesar ◽  
...  
Keyword(s):  
Side Effects ◽  
Prospective Study ◽  
Topical Steroids ◽  
Cutaneous Side Effects ◽  
A Prospective Study

TREATMENT OF TRIGGER FINGERS BY INJECTION OF METHYLPREDNISOLONE ACETATE AND LIDOCAINE (DEPO-MEDROL®)

Hand Surgery ◽  
1996 ◽  
Vol 01 (02) ◽  
pp. 103-105
Author(s):  
J. Joris Hage ◽  
Jaap D.K. Munting
Keyword(s):  
Side Effects ◽  
Prospective Study ◽  
Success Rate ◽  
Adult Patients ◽  
Methylprednisolone Acetate ◽  
Short Term ◽  
Local Injections ◽  
One Year ◽  
A Prospective Study

Thirty-six adult patients with 44 trigger fingers of less than four months' duration entered a prospective study on the efficiency of treatment with local injections of a combination of corticosteroids and lidocaine. From this study it may be concluded that the short-term success rate (93%) of one to three injections of methylprednisolone and lidocaine 2% (Depo-Medrol®) is comparable to that achieved by surgical or percutaneous tenolysis. At one year of follow-up, this success rate still amounted to 86%. In our hands, this therapy is without complications or side effects.

A prospective study of the appearance-related side effects (ARSE) in 638 Japanese patients receiving cancer chemotherapy.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e19516-e19516
Author(s):  
C. Shimizu ◽  
K. Nozawa ◽  
S. Yamamoto ◽  
M. Kakimoto ◽  
Y. Takahashi ◽  
...  
Keyword(s):  
Side Effects ◽  
Prospective Study ◽  
Cancer Chemotherapy ◽  
Japanese Patients ◽  
A Prospective Study

Preliminary Data of a Prospective Study on Neuropsychiatric Side Effects After Initiation of Efavirenz

2001 ◽  
Vol 27 (4) ◽  
pp. 336-343 ◽  
Author(s):  
Jordi Blanch ◽  
Esteban Martínez ◽  
Araceli Rousaud ◽  
José-Luís Blanco ◽  
Miguel-Ángel García-Viejo ◽  
...  
Keyword(s):  
Side Effects ◽  
Prospective Study ◽  
Preliminary Data ◽  
A Prospective Study ◽  
Neuropsychiatric Side Effects

scholarly journals Therapeutic Erythrocytapheresis in the Initial Treatment of Hereditary Hemochromatosis

2012 ◽  
Vol 55 (4) ◽  
pp. 180-185 ◽  
Author(s):  
Vít Řeháček ◽  
Milan Bláha ◽  
Hana Jiroušová ◽  
Jitka Černohorská ◽  
Petr Papoušek
Keyword(s):  
Side Effects ◽  
Prospective Study ◽  
Blood Cells ◽  
Hereditary Hemochromatosis ◽  
Flow Cell ◽  
Current Treatment ◽  
Iron Depletion ◽  
Discontinuous Flow ◽  
Single Procedure ◽  
A Prospective Study

Background: The current treatment of hereditary hemochromatosis (HH) consists of performing periodic whole blood phlebotomies. Erythrocytapheresis (EA) can remove up to three times more red blood cells per single procedure and could thus have a clinical benefit. A prospective study of 30 consecutive cases of HH were included in a periodic EA program. Methods and patients: EA were performed using a discontinuous flow cell separators. The protocol consisted of a bimonthly EA until normalization of the serum ferritin was reached. The aim was to reduce the total erythrocyte volume by 25–35%, eventually, to adjust the amount so that hematocrit would not drop below 0.25. Results: 530 ± 101 ml of erythrocytes were removed (median 517, range 116–761 ml). Iron depletion (ferritin < 20 μg/l) was achieved in all patients after a mean 6.9 ± 7.6 months, median 5 months, range 1–36 months and a mean 14 EA sessions. The procedures were well tolerated and there were no severe side-effects. Conclusions: We conclude that HH patients treated with EA achieved iron depletion quickly under good conditions of tolerance. The efficacy, speed, tolerability, and more favorable schedule of an EA program facilitate treatment of HH.

Sign in / Sign up

Export Citation Format

Share Document